`Tel: 571-272-7822
`
`Paper 66
`Entered: June 29, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`PFIZER, INC., and
`SAMSUNG BIOEPIS CO., LTD.1
`Petitioners,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________
`
`Case IPR2017-01488 (Patent 6,407,213 B1)
` Case IPR2017-01489 (Patent 6,407,213 B1)2
`____________
`
`
`Before ZHENYU YANG, and ROBERT A. POLLOCK,
`Administrative Patent Judges.
`
`POLLOCK, Administrative Patent Judge.
`
`
`
`ORDER
`Granting Request for Oral Argument
`37 C.F.R. § 42.70
`
`
`
`1 Samsung Bioepis Co. Ltd.’s IPR2017-02139 and IPR2017-02140 have
`been joined with IPR2017-01488 and 01489, respectively.
`2
`
`
`
`IPR2017-01488 (Patent 6,407,213 B1)
`IPR2017-01489 (Patent 6,407,213 B1)
`
`
`
`Petitioner Pfizer, Inc., and Patent Owner Genentech, Inc., each
`requested oral argument in this inter partes review trial pursuant to 37
`C.F.R. § 42.70. Papers 65 and 62, respectively.3 Upon consideration, these
`requests are granted. Oral argument shall commence at 3 PM Eastern Time
`on July 16, 2018, on the ninth floor of Madison Building East, 600 Dulany
`Street, Alexandria, Virginia. Each party will have fifty minutes of total time
`to present arguments.
`Petitioners bear the ultimate burden of proof that the claims at issue in
`this review are unpatentable. Therefore, Petitioners will open the hearing by
`presenting argument regarding the pending grounds of unpatentability.
`Patent Owner will then have the opportunity to respond to Petitioners’
`arguments. If desired, Petitioners may reserve rebuttal time to respond to
`arguments presented by Patent Owner.
`The Board will provide a court reporter for the hearing and the
`reporter’s transcript will constitute the official record of the hearing. There
`will be only one transcript, which will be entered into each case. If an
`argument is not applicable to both cases, the presenter should clearly state
`which case the argument is directed to.
`The hearing will be open to the public for in-person attendance, which
`will be accommodated on a first come, first served basis. Certain
`confidential information previously has been sealed under a Protective Order
`entered in these proceedings. See, e.g., Paper 25. The parties are advised to
`not include any confidential information in the demonstrative exhibits or
`specifically refer to it in the arguments. Alternatively, the party originally
`
`
`3 For convenience we refer to papers as numbered in IPR2017-01488.
`
`2
`
`
`
`IPR2017-01488 (Patent 6,407,213 B1)
`IPR2017-01489 (Patent 6,407,213 B1)
`
`
`
`moved to seal the information may waive its request and choose to disclose
`and rely on the information during the oral argument.
`The parties are directed to St. Jude Medical, Cardiology Division, Inc.
`v. The Board of Regents of the University of Michigan, Case IPR2013-00041
`(PTAB Jan. 27, 2014) (Paper 65), for guidance regarding the appropriate
`content of demonstrative exhibits. Pursuant to 37 C.F.R. § 42.70(b),
`demonstrative exhibits are generally served on opposing counsel at least five
`business days before the hearing, and filed with the Board no later than the
`time of the oral argument. By email dated June 28, 2018, Petitioners request
`that we extend the deadline for service of demonstratives to 10 PM Eastern
`Time on July 11, 2018. Ex. 3002. Petitioners aver that Patent Owner does
`not oppose a mutual extension of time. Accordingly, Petitioners’ request is
`granted.
`Notwithstanding 37 C.F.R. § 42.70(b), each party shall, instead of
`filing, provide a courtesy copy of the demonstrative exhibits to the Board by
`emailing them to Trials@uspto.gov no later than 8 AM Eastern Time on July
`13, 2018.
`Due to the nature of the demonstrative exhibits, the panel does not
`anticipate that objections to such exhibits would likely be sustained.
`Nevertheless, to the extent that there is any objection to the propriety of the
`demonstrative exhibits, the parties shall meet and confer in good faith to
`resolve any issue. If the parties cannot resolve the issues regarding the
`demonstrative exhibits on their own, the objecting party may file a one-page
`list of its objections to the demonstrative exhibits with the Board no later
`than 8 AM Eastern Time on July 13, 2018. The objecting party should
`
`3
`
`
`
`IPR2017-01488 (Patent 6,407,213 B1)
`IPR2017-01489 (Patent 6,407,213 B1)
`
`
`
`identify with particularity which portions of the demonstrative exhibits it
`objects to, and include a one-sentence statement of the reason for each
`objection. No argument or further explanation is permitted. The panel will
`schedule a conference call if necessary. Any objection to demonstrative
`exhibits that is not timely presented will be considered waived.
`The parties are reminded that each presenter must identify clearly and
`specifically each demonstrative exhibit (e.g., by slide or screen number)
`referenced during the hearing to ensure the clarity and accuracy of the
`reporter’s transcript. Upon introducing a demonstrative exhibit during oral
`argument that includes argument or evidence subject to a motion to strike or
`exclude, the introducing party shall inform the panel that such motion is
`pending.
`The Board expects lead counsel for each party to be present in person
`at the oral hearing. Any counsel of record, however, may present the party’s
`argument. 4 If either party anticipates that its lead counsel will not be
`attending the oral argument, the parties should initiate a joint telephone
`conference with the Board no later than two business days prior to the oral
`hearing to discuss the matter.
`Any special requests for audio visual equipment should be directed to
`Trials@uspto.gov.
`
`In light of the foregoing, it is:
`
`ORDER
`
`
`4 As per our decision joining, e.g., case IPR2017-02139 with IPR2017-
`01488, we expect counsel for Petitioner Pfizer to present a single argument
`on behalf of Petitioners. Paper 42, 7.
`
`4
`
`
`
`IPR2017-01488 (Patent 6,407,213 B1)
`IPR2017-01489 (Patent 6,407,213 B1)
`
`
`
`ORDERED that oral hearing, conducted pursuant to the procedures
`outlined above, shall commence at 3 PM Eastern Time on July 16, 2018;
`FURTHER ORDERED that the parties shall exchange demonstratives
`no later than 10 PM Eastern Time on July 11, 2018;
`FURTHER ORDERED that each party shall email a courtesy copy of
`its demonstrative exhibits to the Board no later than 8 AM Eastern Time on
`July 13, 2018;
`FURTHER ORDERED that each party may file a one-page list of its
`objections to demonstrative exhibits no later than 8 AM Eastern Time on
`July 13, 2018.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`
`IPR2017-01488 (Patent 6,407,213 B1)
`IPR2017-01489 (Patent 6,407,213 B1)
`
`
`
`
`PETITIONER:
`
`Amanda Hollis
`Stefan Miller, Ph.D.
`Benjamin a. Lasky
`Sarah K. Tsou
`Mark C. McLennan
`Christopher J. Citro
`KIRKLAND & ELLIS LLP
`Amanda.hollis@kirkland.com
`Stefan.miller@kirkland.com
`Benjamin.lasky@kirkland.com
`Sarah.tsou@kirkland.com
`Mark.mclennan@kirkland.com
`Christopher.citro@kirkland.com
`
`PATENT OWNER:
`
`David L. Cavanaugh
`Lauren V. Blakely
`Robert J. Gunther Jr.
`Lisa J. Pirozzlo
`Kevin S. Prussia
`Andrew J. Danford
`WILMER CUTLER PICKERING HALE AND DORR LLP
`David.cavanaugh@wilmrhale.com
`Lauren.blakely@wilmerhale.com
`Robert.Gunther@wilmerhale
`Lisa.Pirozzolo@wilmerhald.com
`Kevin.Prussia@wilmerhale.com
`Andrew.Danford@wilmerhale.com
`
`Adam R. Brausa
`Daralyn J. Durie
`DURIE TANGRI LLP
`abrusa@durietangri.com
`ddurie@durietangri.com
`
`6
`
`